Coronary Thrombosis disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: CRN017 MIFTS: 46	Coronary Thrombosis Categories: Blood diseases, Cardiovascular diseases
Genes Tissues Related diseases Publications Pathways Drugs Expand all tables

Sources

Aliases & Classifications for Coronary Thrombosis

MalaCards integrated aliases for Coronary Thrombosis:

Name: Coronary Thrombosis ¹² ⁵⁴ ⁴⁴ ¹⁵ ¹⁷ ⁷¹

Coronary Artery Thrombosis ¹²

Classifications:

MalaCards categories:
Anatomical: Cardiovascular diseases Blood diseases

See all MalaCards categories (disease lists)

ICD10: ³²

Diseases of the circulatory system

Ischaemic heart diseases

Subsequent myocardial infarction

External Ids:

Disease Ontology ¹² DOID:11847

MeSH ⁴⁴ D003328

SNOMED-CT ⁶⁷ 66514008

ICD10 ³² I22

EFO ¹⁷ EFO_1000883

UMLS ⁷¹ C0010072

Sources

Summaries for Coronary Thrombosis

MalaCards based summary : Coronary Thrombosis, also known as coronary artery thrombosis, is related to angina pectoris and heparin-induced thrombocytopenia. An important gene associated with Coronary Thrombosis is PLAT (Plasminogen Activator, Tissue Type), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Degradation of the extracellular matrix. The drugs Cilostazol and Everolimus have been mentioned in the context of this disorder. Affiliated tissues include heart, endothelial and neutrophil, and related phenotypes are homeostasis/metabolism and cardiovascular system

Wikipedia : ⁷⁴ Coronary thrombosis is defined as the formation of a blood clot inside a blood vessel of the heart. This... more...

Sources

Related Diseases for Coronary Thrombosis

Diseases related to Coronary Thrombosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 337)

#	Related Disease	Score	Top Affiliating Genes
1	angina pectoris	30.6	PLAT F3 CRP
2	heparin-induced thrombocytopenia	30.5	SERPINC1 F3
3	inferior myocardial infarction	30.2	PLG PLAT
4	aspirin resistance	30.2	PTGS2 ITGB3
5	catastrophic antiphospholipid syndrome	30.2	SERPINE1 F3
6	protein s deficiency	30.1	SERPINC1 FGA F3
7	factor viii deficiency	30.0	VWF SERPINC1 F3
8	ischemia	29.9	SELP PLG PLAT GP1BA
9	cardiac rupture	29.9	PLAT CRP
10	coronary stenosis	29.9	VWF SERPINE1 CRP
11	hemophilia b	29.7	VWF SERPINC1 FGA F3
12	coronary aneurysm	29.7	PLG CRP
13	splenic infarction	29.7	SERPINC1 F3 CRP
14	acute anterolateral myocardial infarction	29.7	PLG ITGA2B
15	antithrombin iii deficiency	29.7	SERPINC1 PLG FGA
16	heart aneurysm	29.7	PLG CRP
17	endocarditis	29.6	SERPINE1 SERPINC1 PLAT GP1BA CRP
18	toxic shock syndrome	29.6	SERPINC1 F3 CRP
19	homocysteinemia	29.6	VWF SERPINE1 SERPINC1 CRP
20	infective endocarditis	29.6	SERPINE1 ITGB3 GP1BA CRP
21	arteries, anomalies of	29.5	SERPINE1 PLG F3 CRP
22	nonbacterial thrombotic endocarditis	29.4	SERPINC1 PLG F3 CRP
23	atrial heart septal defect	29.4	SERPINC1 PLG F3 CRP
24	atherosclerosis susceptibility	29.3	VWF SERPINE1 SELP F3 CRP
25	thrombophilia due to thrombin defect	29.3	VWF SERPINE1 SERPINC1 PLAT FGA F3
26	cardiac tamponade	29.2	PLG PLAT F3 CRP
27	atrial fibrillation	29.2	VWF SELP PLAT CRP
28	pulmonary embolism	29.2	VWF SERPINE1 SERPINC1 PLAT GP6 GP1BA
29	thrombocytosis	29.1	VWF SERPINC1 SELP FGA F3 CRP
30	thrombocytopenic purpura, autoimmune	29.0	SELP ITGB3 ITGA2B GP6 GP1BA
31	purpura	28.9	VWF SERPINC1 ITGB3 ITGA2B GP1BA F3
32	portal vein thrombosis	28.9	SERPINE1 SERPINC1 SELP PLAT CRP
33	antiphospholipid syndrome	28.8	VWF SERPINE1 SERPINC1 SELP PLAT F3
34	von willebrand's disease	28.8	VWF SELP PLAT ITGA2B GP1BA F3
35	thrombotic thrombocytopenic purpura	28.7	VWF SERPINC1 SELP PLAT ITGB3 F3
36	thrombophilia	28.7	VWF SERPINE1 SERPINC1 SELP PLAT ITGB3
37	thrombosis	28.7	VWF SERPINE1 SERPINC1 SELP PLG PLAT
38	intermediate coronary syndrome	28.4	VWF SERPINC1 SELP PLG PLAT P2RY12
39	thrombophlebitis	28.4	VWF SERPINE1 SERPINC1 PLG PLAT F3
40	arteriosclerosis	28.3	SERPINE1 SERPINC1 SELP ITGB3 ITGA2B GP1BA
41	intracranial embolism	28.2	VWF SERPINC1 SELP PLG PLAT F3
42	acute myocardial infarction	28.2	VWF SERPINE1 SERPINC1 SELP PLG PLAT
43	disseminated intravascular coagulation	28.1	VWF SERPINE1 SERPINC1 PLG PLAT FGA
44	essential thrombocythemia	28.0	VWF SERPINE1 SERPINC1 SELP ITGB3 ITGA2B
45	carotid artery thrombosis	27.6	VWF SERPINE1 SERPINC1 SELP PLG PLAT
46	intracranial thrombosis	27.4	VWF SERPINC1 SELP PLG PLAT ITGA2B
47	lipoprotein quantitative trait locus	27.2	VWF SERPINE1 SELP PLG PLAT P2RY12
48	myocardial infarction	26.9	VWF SLC6A4 SERPINE1 SERPINC1 SELP PTGS2
49	diabetes mellitus	26.9	VWF SERPINE1 SERPINC1 SELP PTGS2 PLAT
50	hypertension, essential	26.7	VWF SLC6A4 SERPINE1 SERPINC1 SELP PTGS2

Graphical network of the top 20 diseases related to Coronary Thrombosis:

Sources

Symptoms & Phenotypes for Coronary Thrombosis

MGI Mouse Phenotypes related to Coronary Thrombosis:

⁴⁶ (show all 14)

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	homeostasis/metabolism	MP:0005376	10.43	CRP F3 FGA GP1BA GP6 ITGA2B
2	cardiovascular system	MP:0005385	10.41	CRP F3 FGA ITGA2B ITGB3 PLAT
3	hematopoietic system	MP:0005397	10.37	F3 FGA GP1BA GP6 ITGA2B ITGB3
4	cellular	MP:0005384	10.34	F3 FGA GP1BA ITGA2B ITGB3 PLAT
5	immune system	MP:0005387	10.3	CRP F3 FGA GP6 ITGA2B ITGB3
6	integument	MP:0010771	10.21	F3 FGA GP6 ITGA2B ITGB3 PLAT
7	mortality/aging	MP:0010768	10.21	F3 FGA GP6 ITGA2B ITGB3 PLAT
8	digestive/alimentary	MP:0005381	10.16	FGA ITGA2B ITGB3 PLAT PLG PTGS2
9	nervous system	MP:0003631	10.1	F3 FGA ITGA2B ITGB3 PLAT PLG
10	liver/biliary system	MP:0005370	9.95	FGA ITGB3 PLG PTGS2 SELP SERPINC1
11	reproductive system	MP:0005389	9.91	FGA GP6 ITGA2B ITGB3 PLAT PLG
12	respiratory system	MP:0005388	9.7	F3 ITGB3 PLAT PLG PTGS2 SELP
13	skeleton	MP:0005390	9.61	FGA GP6 ITGA2B ITGB3 PLAT PTGS2
14	vision/eye	MP:0005391	9.32	F3 FGA GP6 ITGB3 PLAT PLG

Sources

Drugs & Therapeutics for Coronary Thrombosis

Drugs for Coronary Thrombosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 36)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Cilostazol

Approved, Investigational

Phase 4

73963-72-1

2754

Synonyms:

3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone

3,4-Dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone

6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone

6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone

6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril

6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril

6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxyl)-3,4-dihydrocarobostyril

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one

6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone

6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydroquinolin-2(1H)-one

6-[4-(1-cyclohexyltetrazol-5-yl)butoxy]-3,4-dihydro-1H-quinolin-2-one

73963-72-1

89332-50-3

AC1L1EE2

AC-4334

BRD-K67017579-001-04-2

BRD-K67017579-001-05-9

BRD-K67017579-001-07-5

BRD-K67017579-001-13-3

BRN 3632107

BSPBio_002759

C 0737

C045645

C0737_SIGMA

C20H27N5O2

CHEBI:31401

CHEMBL799

CID2754

cilostazol

Cilostazol

Cilostazol (JP15/USAN/INN)

Cilostazol [INN:JAN]

Cilostazole

Cilostazolum

Cilostazolum [INN-Latin]

CL23867

CPD000058428

D01896

DB01166

EU-0100218

HMS1922N15

HMS2093M14

KBio3_002259

KBioGR_001184

Lopac0_000218

Lopac-C-0737

LS-142693

MLS000028470

MLS000758281

MLS000759507

MLS001076067

MLS002153891

MolPort-001-758-007

NCGC00015207-01

NCGC00015207-02

NCGC00015207-06

NCGC00015207-10

NCGC00022153-02

NCGC00022153-04

NCGC00022153-05

NCGC00022153-06

NCGC00022153-07

OPC 13013

OPC 21

OPC-13013

OPC-21

Otsuka brand of cilostazol

Pletaal

Pletal

Pletal (TN)

Pletal, Cilostazol

S1294_Selleck

SAM001246734

SAM001247085

SMR000058428

SPBio_001256

SPECTRUM1505230

Spectrum2_001118

Spectrum3_001170

Spectrum4_000772

Spectrum5_001762

TL8005113

Tocris-1692

UNII-N7Z035406B

ZINC01552174

Everolimus

Approved

Phase 4

159351-69-6

6442177 70789204

Synonyms:

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

001, RAD

07741_FLUKA

159351-69-6

40-O-(2-hydroxyethyl)-rapamycin

40-O-(2-Hydroxyethyl)-rapamycin

42-O-(2-Hydroxyethyl)rapamycin

Afinitor

Certican

CERTICAN(R)

CHEMBL1201755

D02714

DB01590

everolimus

Everolimus

évérolimus

Everolimus (JAN/USAN/INN)

Everolimus [USAN]

LS-143292

MolPort-003-847-342

MolPort-003-925-588

NCGC00167512-01

NVP-RAD-001

RAD 001

RAD, SDZ

RAD001

RAD-001

RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus

RAD-001C

S1120_Selleck

SDZ RAD

SDZ-RAD

UNII-9HW64Q8G6G

Zortress

Anti-Inflammatory Agents

Phase 4

Analgesics, Non-Narcotic

Phase 4

Fibrinolytic Agents

Phase 4

Anti-Inflammatory Agents, Non-Steroidal

Phase 4

Analgesics

Phase 4

Antirheumatic Agents

Phase 4

Cyclooxygenase Inhibitors

Phase 4

Antipyretics

Phase 4

Protective Agents

Phase 4

Respiratory System Agents

Phase 4

Anti-Asthmatic Agents

Phase 4

Phosphodiesterase Inhibitors

Phase 4

Phosphodiesterase 3 Inhibitors

Phase 4

Neuroprotective Agents

Phase 4

Bronchodilator Agents

Phase 4

Vasodilator Agents

Phase 4

Platelet Aggregation Inhibitors

Phase 4

Immunosuppressive Agents

Phase 4

Immunologic Factors

Phase 4

Clopidogrel

Approved

Phase 3

120202-66-6, 113665-84-2

60606

Synonyms:

( )-(S)-Clopidogrel

(+)-(S)-Clopidogrel

(+)-Clopidogrel

(S)-Clopidogrel

(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate

113665-84-2

AC-19024

AC1L1TKZ

AC1Q41I9

BIDD:GT0284

BMS Brand 1 OF clopidogrel bisulfate

BMS Brand 2 OF clopidogrel bisulfate

BRD-K27721098-065-02-9

BSPBio_003211

C16H16ClNO2S

CGE

CHEBI:37941

CHEMBL1771

CID60606

clopidogrel

Clopidogrel

Clopidogrel (INN)

Clopidogrel (TN)

Clopidogrel [Ban:Inn]

Clopidogrel [BAN:INN]

Clopidogrel [INN:BAN]

Clopidogrel besilate

Clopidogrel besylate

Clopidogrel bisulfate

Clopidogrel bisulphate

Clopidogrel hydrochloride

Clopidogrel mepha

Clopidogrel napadisilate

Clopidogrel sandoz

Clopidogrel sulfate

CLOPIDOGREL SULFATE

clopidogrel, (+)(S)-isomer

Clopidogrel, (+)(S)-isomer

Clopidogrel-mepha

Clopidogrelum

CPD000550475

D07729

DB00758

DivK1c_000787

HMS2090O21

HMS502H09

HSDB 7430

IDI1_000787

Iscover

Isocover

KBio1_000787

KBio2_000545

KBio2_003113

KBio2_005681

KBio3_002431

KBioGR_000689

KBioSS_000545

LS-172232

Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate

methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate

methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate

MLS001165708

MLS001195633

MLS001304711

MolPort-002-885-817

MolPort-003-845-991

NCGC00163329-02

nchem.651-comp8

NINDS_000787

Plavix

Plavix (TN)

SAM002589956

SMR000550475

SPBio_000463

Spectrum_000105

Spectrum2_000512

Spectrum3_001606

Spectrum4_000175

SR 25990

STK580572

STOCK5S-27782

TL8000400

UNII-A74586SNO7

Zyllt

Omeprazole

Approved, Investigational, Vet_approved

Phase 3

73590-58-6

4594

Synonyms:

( -)-Omeprazole

(-)-Omeprazole

(S)-(-)-Omeprazole

(S)-Omeprazole

119141-89-8

131959-78-9

172964-80-6

2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole

2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole

2,3,5-Trimethylpyridine/Omeprazole

5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole

5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole

5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole

5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole

6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole

73590-58-6

AC1L1IIJ

AC-401

AGI-010

AKOS005066653

Antra

Antra mups

Antra MUPS

Audazol

Aulcer

AULCER

Axagon

Belmazol

BIDD:GT0189

Bio-0888

BPBio1_000425

BRD-A55962179-001-04-9

BSPBio_000385

C07324

CAS-73590-58-6

CCRIS 7099

Ceprandal

CHEBI:519601

CHEBI:7772

CHEMBL1503

CID4594

CPD000058847

D00455

Danlox

DB00338

DB00736

Demeprazol

Desec

Dizprazol

DM-3458

Dudencer

Elgam

Emeproton

Emilok

Epirazole

Erbolin

esomeprazol

Esomeprazole

Esomperazole

Esopral

Exter

Gasec

Gastrimut

Gastroloc

Gibancer

H 168/68

H 168-68

H168/68

H-168/68

HMS1528I05

HMS1569D07

HMS2052G17

HMS2090E16

HMS2090F11

HSDB 3575

I06-0705

IDI1_032523

Indurgan

Inhibitron

Inhipump

Lensor

Logastric

Lomac

Losec

Losec, Omesec, Prilosec, Zegerid, Omeprazole

LS-7629

Lucen

Magnesium, omeprazole

Maybridge4_002645

Mepral

Miol

Miracid

MLS000069373

MLS001076112

MLS001424148

MolPort-003-666-741

MolPort-003-807-515

MolPort-003-849-702

Mopral

Morecon

NCGC00016925-01

NCGC00016925-02

NCGC00021522-03

NCGC00021522-04

NCGC00021522-05

Nexiam

Nexium

Nexium IV

Nilsec

Nopramin

Nuclosina

O0359

O104_SIGMA

Ocid

Olexin

Olit

Omapren

Omebeta

Omebeta 20

Omed

Omegast

OMEP

Omepradex

Omepral

Omeprazol

Omeprazol [INN-Spanish]

omeprazole

Omeprazole

Omeprazole (JAN/USP/INN)

Omeprazole [USAN:INN:BAN:JAN]

Omeprazole delayed-release

Omeprazole magnesium

Omeprazole pellets

Omeprazole sodium

Omeprazolum

Omeprazolum [INN-Latin]

Omeprazon

Omeprazone

Omeprol

Omesek

Omez

Omezol

Omezolan

Omid

Omisec

Omizac

OMP

Ompanyt

OMZ

Ortanol

Osiren

Ozoken

Paprazol

Parizac

Pepticum

Pepticus

Peptilcer

Prazentol

Prazidec

Prazolit

Prestwick_808

Prestwick0_000493

Prestwick1_000493

Prestwick2_000493

Prestwick3_000493

Prilosec

Prilosec (TN)

Prilosec otc

Prilosec OTC

Procelac

Proclor

Prysma

Ramezol

Regulacid

Result

S1389_Selleck

SAM001246900

SAN-15

Sanamidol

Secrepina

SMR000058847

Sodium, omeprazole

SPBio_002306

STK623746

Tedec ulceral

Tedec Ulceral

TL8005099

Ulceral

Ulcesep

Ulcometion

Ulcozol

Ulcsep

Ulsen

Ultop

Ulzol

UNII-KG60484QX9

UPCMLD-DP075

UPCMLD-DP075:001

Victrix

Zefxon

Zegerid

Zepral

Zimor

Zoltum

2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid

Phase 3

Neurotransmitter Agents

Phase 3

Purinergic P2Y Receptor Antagonists

Phase 3

Sirolimus

Approved, Investigational

Phase 1, Phase 2

53123-88-9

5284616 6436030

Synonyms:

(-)-rapamycin

(-)-Rapamycin

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-{(2S)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.0(4,9)]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone

1fkb

1pbk

23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine

23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine

23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29

3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

53123-88-9

A422989, NSC226080

AC1L1JH9

AC1L7MJ9

AC1L9ZMV

AC-722

Ambotz53123-88-9

Antibiotic ay 22989

Antibiotic AY 22989

AY 22989

AY22989

AY-22989

BIDD:PXR0165

Bio1_000293

Bio1_000782

Bio1_001271

Bio2_000375

Bio2_000855

BiomolKI2_000084

C07909

C51H79NO13

CBiol_002007

CCRIS 9024

CHEBI:100923

CHEBI:9168

CHEMBL413

CID10213190

CID10795871

CID11949238

CID11959112

CID313006

CID478951

CID5040

CID5284616

CID5358081

CID5374464

CID5460439

CID5497196

CID5924240

CID6436030

CID6610270

CID6610346

CID6711160

CID6713081

CID9833581

CID9854379

CID9854380

CID9962926

CID9962928

D00753

DB00877

DE-109

DivK1c_006936

FT-0082351

heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy

HMS2089A21

HSDB 7284

KBio1_001880

KBio2_000410

KBio2_002978

KBio2_005546

KBio3_000779

KBio3_000780

KBioGR_000410

KBioSS_000410

LCP-Siro

LMPK06000003

LS-143290

MLS000028373

MolMap_000043

MolPort-003-959-433

MS-R001

NCGC00021305-05

nchembio.100-comp4

nchembio.2007.42-comp2

nchembio.79-comp1

nchembio762-comp1

nchembio883-comp3

NCI60_001851

NCIMech_000355

NSC 226080

NSC226080

Perceiva

QTL1_000069

R0395_SIAL

R0395_SIGMA

RAP

RAPA

Rapammune

Rapamune

Rapamune (TN)

rapamycin

Rapamycin

Rapamycin (TN)

Rapamycin C-7, analog 4

Rapamycin from Streptomyces hygroscopicus

Rapamycin Immunosuppressant Drug

Rapamysin

RPM

S1039_Selleck

SIIA 9268A

SILA 9268A

SILA9268A

sirolimus

Sirolimus

Sirolimús

Sirolimus (RAPAMUNE)

Sirolimus (USAN/INN)

Sirolimus [USAN:BAN:INN]

Sirolimus, Rapamune,Rapamycin

Sirolimusum

SMP1_000255

SMR000058564

SpecPlus_000840

UNII-W36ZG6FT64

UNM-0000358684

Wy 090217

WY-090217

Immunoglobulins

Phase 1, Phase 2

Antibodies

Phase 1, Phase 2

Chlorhexidine

Approved, Vet_approved

55-56-1

9552079 2713

Synonyms:

1,1 inverted exclamation marka-Hexamethylenebis[5-(4-chlorophenyl)biguanide]

1,1'-Hexamethylene bis(5-(p-chlorophenyl)biguanide)

1,1'-Hexamethylenebis(5-(p-chlorophenyl)biguanide)

1,1'-Hexamethylenebis[5-(4-chlorophenyl)biguanide

1,6-Bis(5-(p-chlorophenyl)biguandino)hexane

1,6-Bis(p-chlorophenyldiguanido)hexane

1,6-Di(4'-chlorophenyldiguanido)hexane

1,6-Di(N-p-chlorophenyldiguanido)hexane

24798_FLUKA

282227_ALDRICH

348031_ALDRICH

4-12-00-01201 (Beilstein Handbook Reference)

55-56-1

AB00053427

AB1003159

AVAGARD

BPBio1_000272

BRN 2826432

BSPBio_000246

BSPBio_001977

C06902

C22H30Cl2N10

CAS-55-56-1

CCRIS 9230

CHEBI:3614

CHEMBL790

Chlorhexidin

Chlorhexidin [Czech]

chlorhexidine

Chlorhexidine

Chlorhexidine (INN)

Chlorhexidine [INN:BAN]

Chlorhexidine Base

Chlorhexidine gluconate

Chlorhexidinum

Chlorhexidinum [INN-Latin]

CID9552079

Cloresidina

Cloresidina [DCIT]

Clorhexidina

Clorhexidina [INN-Spanish]

D07668

DB00878

Decanoylacetaldehyde Sodium Sulfide

Dentisept

Dentisept [veterinary]

Dentisept [veterinary] (TN)

DivK1c_000761

EINECS 200-238-7

Fimeil

Hexadol

Hibiclens

Hibispray

Hibistat

HMS1568M08

HSDB 7196

I06-0621

I14-0050

IDI1_000761

KBio1_000761

KBio2_000717

KBio2_003285

KBio2_005853

KBio3_001197

KBioGR_000774

KBioSS_000717

Lisium (*Dihydrochloride*)

LS-43917

Merfen-incolore

Merfen-incolore (TN)

MK-412A

MLS001332387

MLS001332388

MLS002154209

MolPort-002-541-741

N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradeca- nediimidamide

N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide

N,N'-Bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide

N,N''''-hexane-1,6-diylbis[N'-(4-chlorophenyl)(imidodicarbonimidic diamide)]

N',N'''''-hexane-1,6-diylbis[N-(4-chlorophenyl)(imidodicarbonimidic diamide)]

NCGC00016246-01

NCGC00091025-01

NCGC00091025-02

NINDS_000761

Nolvasan

Nolvasan (*Diacetate*)

Novalsan

NSC526936

Oro-Clense

Peridex

Periogard

Prestwick_53

Prestwick0_000143

Prestwick1_000143

Prestwick2_000143

Prestwick3_000143

QTL1_000020

Rotersept

Savloclens

Savlon babycare

Sebidin A

SMR000857146

Sodium Houttuyfonamide

Soretol

SPBio_000210

SPBio_002185

Spectrum_000237

Spectrum2_000135

Spectrum3_000339

Spectrum4_000277

Spectrum5_001322

Sterido

Sterilon

STK089248

STOCK1S-18831

Superspray

Tubulicid

UNII-R4KO0DY52L

Miconazole

Approved, Investigational, Vet_approved

22916-47-8

4189

Synonyms:

(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole

1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole

1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole

1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole

1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole

1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole

1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole

1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole

22832-87-7 (NITRATE)

22916-47-8

75319-47-0

AB00053500

AC1L1HM1

Aflorix(nitrate)

AKOS001574474

Albistat(nitrate)

Andergin(nitrate)

BPBio1_000279

BRD-A82396632-001-03-0

BRD-A82396632-008-02-7

Brentan

BRN 0965511

BSPBio_000253

BSPBio_002033

CCRIS 7924

CHEBI:6923

CHEMBL91

CID4189

Conofite(nitrate)

CPD-4501

D00416

Dactarin

Daktarin IV

DB01110

DivK1c_000156

EINECS 245-324-5

Epi-Monistat(nitrate)

Esteve brand OF miconazole

Femizol-M

Florid(nitrate)

Gyno-Daktar(nitrate)

HMS1568M15

HMS2090B21

I14-14342

IDI1_000156

imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)

Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)

Janssen cilag brand OF miconazole

Janssen-cilag brand OF miconazole

Johnston and johnston brand OF miconazole nitrate

KBio1_000156

KBio2_001445

KBio2_004013

KBio2_006581

KBio3_001533

KBioGR_000581

KBioSS_001445

Lotrimin AF(nitrate)

LS-78378

MCZ

Micantin (nitrate)

Miconasil nitrate

Miconasil Nitrate

Miconazol

Miconazol [INN-Spanish]

miconazole

Miconazole

Miconazole (JP15/USP/INN)

Miconazole [USAN:BAN:INN:JAN]

Miconazole 3

Miconazole 3 Combination Pack

Miconazole 7 Combination Pack

Miconazole esteve brand

Miconazole janssen-cilag brand

Miconazole nitrate

Miconazole nitrate salt

Miconazole-7

Miconazolo

Miconazolo [DCIT]

Miconazolum

Miconazolum [INN-Latin]

Micozole

Minostate

MJR 1762

MLS002222203

MolPort-002-557-553

Monazole 7

Monista (nitrate)

Monistat

Monistat (TN)

Monistat 1 Combination Pack

Monistat 3 Dual-Pak

Monistat 3 Vaginal Ovules

Monistat 5 Tampon

Monistat 7 Dual-Pak

Monistat 7 Vaginal Suppositories

Monistat Dual- PAK

Monistat IV

Monistat iv (TN)

Monistat-Derm

NCI60_001353

NCI60_001380

NINDS_000156

Nitrate, miconasil

Nitrate, miconazole

Novo-Miconazole Vaginal Ovules

NSC 170986

NSC169434

NSC170986

Oprea1_091955

Prestwick_335

Prestwick0_000067

Prestwick1_000067

Prestwick2_000067

Prestwick3_000067

R 18134

R-14,889

SMR001307249

SPBio_000976

SPBio_002174

Spectrum_000965

Spectrum2_001048

Spectrum3_000507

Spectrum4_000061

Spectrum5_001297

STK834405

STOCK1S-93556

UNII-7NNO0D7S5M

Vusion

Zimycan

Clotrimazole

Approved, Vet_approved

23593-75-1

2812

Synonyms:

(Chlorotrityl)imidazole

1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole

1-(a-(2-Chlorophenyl)benzhydryl)imidazole

1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole

1-(O-Chloro-a,a-diphenylbenzyl)imidazole

1-(O-Chloro-alpha,alpha-diphenylbenzyl)imidazole

1-(o-Chlorotrityl)imidazole

1-(O-Chlorotrityl)imidazole

1-(o-Chloro-α,α-diphenylbenzyl)imidazole

1-(O-Chloro-α,α-diphenylbenzyl)imidazole

1-(α-(2-Chlorophenyl)benzhydryl)imidazole

1-(Α-(2-chlorophenyl)benzhydryl)imidazole

117829-71-7

23593-75-1

33894_FLUKA

33894_RIEDEL

3ACDFDF8-38E3-4368-85D0-BDF8AE1E6591

AB00051951

AC1L1EIW

AC-279

B 5097

BAY 5097

Bay b 5097

BAY b 5097

Bay b 9057

BAY b5097

BAY-5097

Bay-B 5097

BAYb 5097

Bayer brand 1 OF clotrimazole

Bayer Brand 1 of Clotrimazole

Bayer brand 2 OF clotrimazole

Bayer Brand 2 of Clotrimazole

BIDD:GT0450

BIDD:PXR0036

Bio-0442

BPBio1_000126

BRN 0622318

BSPBio_000114

BSPBio_002057

C 6019

C06922

C22H17ClN2

C6019_SIGMA

Canesten

Canesten 1-day cream combi-pak

Canesten 1-Day Cream Combi-Pak

Canesten 1-day therapy

Canesten 1-Day Therapy

Canesten 3-day therapy

Canesten 3-Day Therapy

Canesten 6-day therapy

Canesten 6-Day Therapy

Canesten combi-pak 1-day therapy

Canesten Combi-Pak 1-Day Therapy

Canesten combi-pak 3-day therapy

Canesten Combi-Pak 3-Day Therapy

Canesten cream

Canesten Cream

Canesten solution

Canesten Solution

Canestene

Canestine

Canifug

CAS-23593-75-1

CCRIS 6245

CHEBI:3764

CHEMBL104

Chlotrimazole

CID2812

Cimitidine

Clomatin

Clotrimaderm

Clotrimaderm cream

Clotrimazol

Clotrimazol [INN-Spanish]

clotrimazole

Clotrimazole

Clotrimazole (JP15/USP/INN)

Clotrimazole [USAN:INN:BAN:JAN]

Clotrimazole schering brand

Clotrimazole Schering Brand

Clotrimazolum

Clotrimazolum [INN-Latin]

clotrimeizol

CPD000058306

CPD-8926

Cutistad

D00282

D003022

DB00257

Desamix F

DivK1c_000665

DRG-0072

EINECS 245-764-8

Empecid

Esparol

EU-0100315

FB 5097

FB b 5097

Fem care

Fem Care

FemCare

Gino-Lotremine

Gyne lotrimin

Gyne-lotrimin

Gyne-Lotrimin

Gyne-lotrimin 3

Gyne-Lotrimin 3

Gyne-lotrimin 3 combination pack

Gyne-Lotrimin 3 Combination Pack

Gyne-lotrimin combination pack

Gyne-Lotrimin Combination Pack

Gyne-lotrimin3

Gyne-lotrimin3 combination pack

Gynix

HMS1568F16

HMS1920O21

HMS2051E11

HMS2091G10

HMS502B07

HSDB 3266

I01-3474

IDI1_000665

Kanesten

KBio1_000665

KBio2_001823

KBio2_004391

KBio2_006959

KBio3_001277

KBioGR_000850

KBioSS_001823

Klotrimazole

Lopac0_000315

Lopac-C-6019

Lotrimax

Lotrimin

Lotrimin (TN)

Lotrimin af

Lotrimin Af

Lotrimin af cream

Lotrimin AF Cream

Lotrimin af jock-itch cream

Lotrimin AF Jock-Itch Cream

Lotrimin af lotion

Lotrimin AF Lotion

Lotrimin af solution

Lotrimin AF Solution

Lotrimin cream

Lotrimin Cream

Lotrimin lotion

Lotrimin Lotion

Lotrimin solution

Lotrimin Solution

Lotrisone

LS-78271

MLS000028502

MLS000758243

MLS001423972

MolPort-002-557-756

mono-Baycuten

Monobaycuten

Mono-baycuten

Mycelax

Mycelex

Mycelex (TN)

Mycelex 7

Mycelex cream

Mycelex Cream

Mycelex g

Mycelex G

Mycelex otc

Mycelex OTC

Mycelex solution

Mycelex Solution

Mycelex troches

Mycelex Troches

Mycelex twin pack

Mycelex Twin Pack

Mycelex: mycosporinrimazole

Mycelex: MycosporinRimazole

Mycelex-7

Mycelex-7 combination pack

Mycelex-7 Combination Pack

Mycelex-g

Mycelex-G

Myclo cream

Myclo Cream

Myclo solution

Myclo Solution

Myclo spray solution

Myclo Spray Solution

Myclo-gyne

Myclo-Gyne

Mycofug

Mycosporin

Mykosporin

Nalbix

NCGC00015251-01

NCGC00015251-02

NCGC00015251-03

NCGC00015251-09

NCGC00093761-01

NCGC00093761-02

NCGC00093761-03

NCGC00093761-04

NCGC00093761-05

NCGC00093761-06

nchembio.65-comp9

nchembio790-comp30

NCIMech_000609

Neo-zol cream

Neo-Zol Cream

NINDS_000665

NSC 257473

NSC257473

Otomax

Pan-Fungex

Pedisafe

Prestwick_120

Prestwick0_000267

Prestwick1_000267

Prestwick2_000267

Prestwick3_000267

QTL1_000024

Rimazole

S1606_Selleck

SAM001247056

Schering brand OF clotrimazole

Schering Brand of Clotrimazole

SMR000058306

SPBio_000176

SPBio_002333

Spectrum_001343

SPECTRUM1500200

Spectrum2_000128

Spectrum3_000359

Spectrum4_000295

Spectrum5_000781

Stiemazol

STK700023

Tibatin

Trimysten

Trivagizole 3

UNII-G07GZ97H65

Veltrim

ZINC03807804

Thrombin

Approved, Investigational

Chlorhexidine gluconate

Antifungal Agents

Antibiotics, Antitubercular

Interventional clinical trials:

(show all 16)

#	Name	Status	NCT ID	Phase	Drugs
1	Effect of aSpirin Versus CilOstazol for Inhibition of Antiplatelet aggRegaTion in Type 2 DM Patients	Unknown status	NCT02933788	Phase 4	Cilostazol;Acetylsalicylic acid
2	Evaluation of Late Clinical Events After Drug-eluting Versus Bare-metal Stents in Patients at Risk: BAsel Stent Kosten Effektivitäts Trial - PROspective Validation Examination Part II (BASKET-PROVE II)	Completed	NCT01166685	Phase 4
3	A Clinical Evaluation of Dual Antiplatelet Therapy Duration Following Treatment With the Medtronic Endeavor Zotarolimus-eluting Coronary Stent	Completed	NCT00963781	Phase 4	Reduced duration (6 months) DAPT
4	Comparative Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control on the Gastric Lesions Induced by the Aspirin With the Low Dose Among Patients Treated With the Long Course	Withdrawn	NCT00713947	Phase 4	during one week for the active treatments;Pantoprazole;Placebo Formula 515
5	A Randomized, Double-Blind, Placebo-Controlled Study to Examine the Safety and Efficacy of Veliflapon (DG-031) in Reducing the Risk of Acute Cardiovascular Events in African American Patients With Coronary Artery Disease(The LTCAD Study).	Suspended	NCT00353067	Phase 3	veliflapon (DG-031)
6	A Randomized, Double-Blind, Double-Dummy, Parallel Group, Phase 3 Efficacy and Safety Study of CGT-2168 Compared With Clopidogrel to Reduce Upper Gastrointestinal Events Including Bleeding and Symptomatic Ulcer Disease	Terminated	NCT00557921	Phase 3	CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;Plavix (clopidogrel 75 mg) and aspirin
7	Evaluation of Neointimal Healing of Endothelial Progenitor Cell Capturing Sirolimus-Eluting (COMBO) Stent by Optical Coherence Tomography: the EGO-COMBO Pilot Study	Completed	NCT01274234	Phase 1, Phase 2
8	Angiographic and Intravascular Ultrasound (IVUS) Follow-up After Simultaneously Implanted Different Drug-eluting Stents in Same Individuals	Unknown status	NCT00973375
9	Periprocedural Myocardial Infarction: the Role of Human Neutrophil Peptide-1 to 3	Unknown status	NCT02591264
10	Pilot Study Investigating the Use of a Variety of Assays to Detect Individual Response to Antiplatelet Therapy	Unknown status	NCT00327041
11	Mechanisms of Very Late Bioresorbable Scaffold Thrombosis Assessed by Optical Coherence Tomography: Insights From the International INVEST Registry	Completed	NCT03180931
12	A Prospective Registry for the Use of CypherTM Sirolimus-Eluting Stents In Patients With Coronary Artery Disease Treated With Percutaneous Coronary Interventions at Scripps Clinic	Completed	NCT00714623
13	Study of Myeloid-related Protein 8/14 and Additional Biomarkers (Multi Marker Approach) for Early Diagnosis and Risk Stratification in Patients Presenting With Acute Chest Pain at the Emergency Department	Completed	NCT00657436
14	Prospective Evaluation of Acetyl-Coenzyme A Carboxylase Phosphorylation State in Platelets in Atherothrombotic Coronary Artery Disease.	Completed	NCT03034148
15	Optical Frequency Domain Imaging-Quantified Intracoronary Thrombus Mass During Primary Percutaneous Coronary Intervention, Its Relationship With Antiplatelet Pretreatment Effect And Its Impact On Myocardial Reperfusion	Completed	NCT03342521
16	EKG Criteria and Identification of Acute Coronary Occlusion	Recruiting	NCT03863327

Search NIH Clinical Center for Coronary Thrombosis

Inferred drug relations via UMLS ⁷¹ / NDF-RT ⁵¹ :

heparin

heparin calcium

heparin sodium

HEPARIN SODIUM (BEEF LUNG)

heparin sodium, bovine

heparin sodium, porcine

Tenecteplase

Urokinase

Cochrane evidence based reviews: coronary thrombosis

Sources

Genetic Tests for Coronary Thrombosis

Sources

Anatomical Context for Coronary Thrombosis

MalaCards organs/tissues related to Coronary Thrombosis:

⁴⁰

Heart, Endothelial, Neutrophil, Smooth Muscle, Kidney, Lung, Myeloid

Sources

Publications for Coronary Thrombosis

Articles related to Coronary Thrombosis:

(show top 50) (show all 2376)

#	Title	Authors	PMID	Year
1	[Annexin A5 inhibits homocysteine-induced tissue factor expression and activity in vascular smooth muscle cells]. ⁵⁴ ⁶¹	Li J...Hong M	20137335	2009
2	Atherothrombosis: role of tissue factor; link between diabetes, obesity and inflammation. ⁵⁴ ⁶¹	Meerarani P...Badimon JJ	17249334	2007
3	Rapid release of active tissue factor from human arterial smooth muscle cells under flow conditions. ⁵⁴ ⁶¹	Stampfuss JJ...Weber AA	16528008	2006
4	Detection of von Willebrand factor and tissue factor in platelets-fibrin rich coronary thrombi in acute myocardial infarction. ⁶¹ ⁵⁴	Yamashita A...Asada Y	16377278	2006
5	[Regulatory effect of IL-10 on expression of tissue factor induced by IL-6 in peripheral blood mononuclear cells]. ⁶¹ ⁵⁴	Hong M...Song SJ	15972146	2005
6	Angiographic demonstration of coronary dethrombosis with eptifibatide. ⁶¹ ⁵⁴	Colombo A...Viecca M	15156011	2004
7	Tumor necrosis factor alpha activates the human plasminogen activator inhibitor-1 gene through a distal nuclear factor kappaB site. ⁶¹ ⁵⁴	Hou B...Vaughan DE	14963043	2004
8	How vitronectin binds PAI-1 to modulate fibrinolysis and cell migration. ⁶¹ ⁵⁴	Zhou A...Read RJ	12808446	2003
9	Plasminogen activator inhibitor-1, which is released from blood product transfusions, might be associated with (sub)acute thrombosis after coronary dilatation and stenting: a case report. ⁵⁴ ⁶¹	Sabovic M...Zorman SK	12644882	2003
10	Glycoprotein IIIa Pl(A1/A2) polymorphism and sudden cardiac death. ⁵⁴ ⁶¹	Mikkelsson J...Karhunen PJ	11028489	2000
11	Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly. ⁶¹ ⁵⁴	Mikkelsson J...Karhunen PJ	10928474	2000
12	Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. ⁵⁴ ⁶¹	Arnaud E...Aiach M	10712418	2000
13	The PlA2 polymorphism of the platelet glycoprotein IIIA gene as a risk factor for acute renal allograft rejection. ⁶¹ ⁵⁴	Salido E...Torres A	10589700	1999
14	Glycoprotein IIIa Pl(A) polymorphism associates with progression of coronary artery disease and with myocardial infarction in an autopsy series of middle-aged men who died suddenly. ⁶¹ ⁵⁴	Mikkelsson J...Karhunen PJ	10521390	1999
15	Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. ⁶¹ ⁵⁴	Badimon JJ...Badimon L	10199872	1999
16	Association between the ACE genotype and coronary artery disease. Insights from studies on restenosis, vasomotion and thrombosis. ⁶¹ ⁵⁴	Bauters C...Amouyel P	9796837	1998
17	Coronary thrombosis associated with antithrombin-III deficiency. ⁶¹ ⁵⁴	Loubser PG...Attar M	9327319	1997
18	Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. ⁵⁴ ⁶¹	Ossei-Gerning N...Grant PJ	9012634	1997
19	Identification of active tissue factor in human coronary atheroma. ⁶¹ ⁵⁴	Marmur JD...Taubman MB	8822973	1996
20	Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosis. ⁵⁴ ⁶¹	Martin U...Fischer S	8735626	1996
21	Enhanced platelet aggregability under high shear stress after treadmill exercise in patients with effort angina. ⁶¹ ⁵⁴	Tokuue J...Ikeda Y	8725732	1996
22	Attenuation of the synthesis of plasminogen activator inhibitor type 1 by niacin. A potential link between lipid lowering and fibrinolysis. ⁶¹ ⁵⁴	Brown SL...Fujii S	7641354	1995
23	Novel antithrombotic approaches to coronary artery disease. ⁵⁴ ⁶¹	Topol EJ	7863968	1995
24	Coronary thrombolysis with Desmodus salivary plasminogen activator in dogs. Fast and persistent recanalization by intravenous bolus administration. ⁶¹ ⁵⁴	Witt W...Schleuning WD	8026028	1994
25	Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries. ⁵⁴ ⁶¹	Yao SK...Willerson JT	1451271	1992
26	Reduced synthesis of tissue plasminogen activator by vascular endothelium during acute myocardial infarction. ⁶¹ ⁵⁴	Norris RM...White HD	1497553	1992
27	Role of heparin in coronary thrombolysis. ⁵⁴ ⁶¹	Eisenberg PR	1555478	1992
28	Double bolus administration of the novel recombinant plasminogen activator BM 06.022 improves coronary blood flow after reperfusion in a canine model of coronary thrombosis. ⁵⁴ ⁶¹	Martin U...Strein K	1606285	1992
29	Thrombolytic effects of a novel modified tissue plasminogen activator, E6010, on coronary thrombosis in the pig. ⁶¹ ⁵⁴	Adachi H...Shoji T	1513078	1992
30	Sudden cardiac death-update. ⁶¹	Markwerth P...Dettmeyer R	33349905	2021
31	A Review of Coronary Artery Thrombosis: A New Challenging Finding in COVID-19 Patients and ST-elevation Myocardial Infarction. ⁶¹	Kermani-Alghoraishi M	33218787	2021
32	Coronary spasm and optical coherence tomography defined plaque erosion causing ST-segment-elevation acute myocardial infarction in a patient with COVID-19 pneumonia. ⁶¹	Nakao M...Sasano T	33052252	2021
33	Coronary Thrombosis and Acute Myocardial Infarction in a Child Following Device Closure of Coronary Artery Fistula. ⁶¹	Lahiri S...Gowda ST	33454294	2021
34	Acute myocardial infarction and large coronary thrombosis in a patient with COVID-19. ⁶¹	Tedeschi D...Tumscitz C	32767631	2021
35	Anatomic and Flow Characteristics of Left Anterior Descending Coronary Artery Angiographic Stenoses Predisposing to Myocardial Infarction. ⁶¹	Katritsis DG...Cutlip D	33220322	2021
36	Diagnosing coronary thrombosis using multiphase post-mortem CT angiography (MPMCTA): A case study. ⁶¹	Jessika C...Enrico S	33591864	2021
37	Acute Coronary Artery Thrombosis in a Patient With Non-Small Cell Lung Cancer. ⁶¹	Lahmidi I...Elouafi N	33457143	2021
38	Coronary thrombosis due to heparin-induced thrombocytopenia after percutaneous coronary intervention: Easy to miss, uneasy to prevent. ⁶¹	Mele M...Brunetti ND	33489138	2021
39	Recurrent coronary thrombotic events in a moderate case of COVID-19. ⁶¹	Muguerza J...Loizeau PA	33500300	2021
40	Antithrombotic / Antiplatelet Therapy in Patients with Stable Coronary Artery Disease and after Acute Coronary Syndrome. ⁶¹	Cruz Rodriguez JB...Siddiqui T	33290202	2020
41	COVID-19 patient with coronary thrombosis supported with ECMO and Impella 5.0 ventricular assist device: a case report. ⁶¹	Valchanov K...Berman M	33442588	2020
42	Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction. ⁶¹	Blasco A...Bellas C	33372956	2020
43	Transcatheter Closure of Large Coronary-Cameral Fistulas Using the Patent Ductus Arteriosus Occluder or Amplatzer Vascular Plugs. ⁶¹	Tang L...Zhou SH	33191343	2020
44	NIRS-IVUS for Differentiating Coronary Plaque Rupture, Erosion and Calcified Nodule in Acute Myocardial Infarction. ⁶¹	Terada K...Akasaka T	33221211	2020
45	Relapse of chronic obstructive pulmonary disease and myocardial infarction: what is the connection? ⁶¹	Terrosu P	33239991	2020
46	Serious Right Coronary Artery Thrombosis Revealing Behçet's Disease in a Female Patient: A Case Report. ⁶¹	Mouedder F...Elouafi N	33312783	2020
47	Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells. ⁶¹	Cimmino G...Cirillo P	33232770	2020
48	Coronary Thrombosis From Superficial Calcific Sheet. ⁶¹	Gonzalvez-Garcia A...Lopez-Sendon JL	32999102	2020
49	Coronary and cerebral thrombosis in a young patient after mild COVID-19 illness: a case report. ⁶¹	Ranard LS...Masoumi A	33200109	2020
50	Ultrasonographic Assessment During Cardiopulmonary Resuscitation. ⁶¹	Lien WC...Chen WJ	33165330	2020

Sources

Genes for Coronary Thrombosis

Genes related to Coronary Thrombosis (0 elite genes):

(show all 18)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubMed IDs
1	PLAT	Plasminogen Activator, Tissue Type	Protein Coding	23.51	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications (show sections)	8026028 15156011 8735626 (more) 7863968 1451271 1606285 1513078 1555478 1497553
2	ITGB3	Integrin Subunit Beta 3	Protein Coding	19.61	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications (show sections)	10589700 11028489 10521390
3	SERPINC1	Serpin Family C Member 1	Protein Coding	19.47	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴ GeneCards inferred via : Publications (show sections)	7863968 9327319
4	SERPINE1	Serpin Family E Member 1	Protein Coding	14.87	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴	10928474 14963043 9796837 (more) 12644882 7641354 9012634 12808446
5	F3	Coagulation Factor III, Tissue Factor	Protein Coding	14.13	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴	10712418 15972146 10199872 (more) 16377278 8822973 17249334 16528008 20137335
6	VWF	Von Willebrand Factor	Protein Coding	13.74	DISEASES inferred ¹⁵ Novoseek inferred ⁵⁴	16377278 8725732
7	P2RY12	Purinergic Receptor P2Y12	Protein Coding	13.71	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
8	GP6	Glycoprotein VI Platelet	Protein Coding	13.56	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
9	GP1BA	Glycoprotein Ib Platelet Subunit Alpha	Protein Coding	13.32	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
10	POU2F3	POU Class 2 Homeobox 3	Protein Coding	12.76	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
11	PTGS2	Prostaglandin-Endoperoxide Synthase 2	Protein Coding	10.87	DISEASES inferred ¹⁵ GeneCards inferred via : Publications (show sections)
12	ITGA2B	Integrin Subunit Alpha 2b	Protein Coding	7.78	DISEASES inferred ¹⁵
13	PLG	Plasminogen	Protein Coding	7.64	DISEASES inferred ¹⁵
14	FGA	Fibrinogen Alpha Chain	Protein Coding	6.78	GeneCards inferred via : Publications (show sections)
15	SERPINF1	Serpin Family F Member 1	Protein Coding	6.78	GeneCards inferred via : Publications (show sections)
16	SLC6A4	Solute Carrier Family 6 Member 4	Protein Coding	6.78	GeneCards inferred via : Publications (show sections)
17	SELP	Selectin P	Protein Coding	6.49	DISEASES inferred ¹⁵
18	CRP	C-Reactive Protein	Protein Coding	6.31	DISEASES inferred ¹⁵

Sources

Variations for Coronary Thrombosis

Sources

Expression for Coronary Thrombosis

Search GEO for disease gene expression data for Coronary Thrombosis.

Sources

Pathways for Coronary Thrombosis

Pathways related to Coronary Thrombosis according to GeneCards Suite gene sharing:

(show all 22)

#	Super pathways	Score	Top Affiliating Genes
1	Response to elevated platelet cytosolic Ca2+ ⁶⁵ Show member pathways Disinhibition of SNARE formation ⁶⁵ Hemostasis ⁶⁵ Platelet activation, signaling and aggregation ⁶⁵ Platelet degranulation ⁶⁵	12.85	VWF SERPINE1 SERPINC1 SELP PLG PLAT
2	Degradation of the extracellular matrix ⁶⁵ Show member pathways Collagen degradation ⁶⁵ Extracellular matrix organization ⁶⁵	12.64	SERPINE1 PLG ITGB3 ITGA2B FGA
3	Folate Metabolism ¹ Show member pathways Selenium Micronutrient Network ¹ thioredoxin pathway ¹ Vitamin B12 Metabolism ¹	12.23	SERPINE1 PTGS2 PLG PLAT CRP
4	Paradoxical activation of RAF signaling by kinase inactive BRAF ⁶⁵ Show member pathways MAP2K and MAPK activation ⁶⁵ Signaling by high-kinase activity BRAF mutants ⁶⁵ Signaling by moderate kinase activity BRAF mutants ⁶⁵ Signaling by RAS mutants ⁶⁵	12.17	VWF ITGB3 ITGA2B FGA
5	ECM-receptor interaction ³⁶ Show member pathways Integrin cell surface interactions ⁶⁵	12.04	VWF ITGB3 ITGA2B GP6 GP1BA FGA
6	Complement and coagulation cascades ³⁶ ¹	12.03	VWF SERPINE1 SERPINC1 PLG PLAT FGA
7	Oncogenic MAPK signaling ⁶⁵ Show member pathways Signaling by BRAF and RAF fusions ⁶⁵	11.97	VWF ITGB3 ITGA2B FGA
8	Adhesion ⁴	11.91	SERPINE1 PLG ITGB3 F3
9	Platelet activation ³⁶	11.89	VWF P2RY12 ITGB3 ITGA2B GP6 GP1BA
10	Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers ⁶⁴	11.85	ITGB3 ITGA2B GP1BA
11	Integrin alphaIIb beta3 signaling ⁶⁵ Show member pathways GRB2-SOS provides linkage to MAPK signaling for Integrins ⁶⁵ p130Cas linkage to MAPK signaling for integrins ⁶⁵ Platelet Aggregation (Plug Formation) ⁶⁵	11.79	VWF ITGB3 ITGA2B GP1BA FGA
12	Hematopoietic cell lineage ³⁶	11.77	ITGB3 ITGA2B GP1BA
13	Angiogenesis (CST) ⁴	11.76	VWF PTGS2 ITGB3 F3
14	Cell adhesion_ECM remodeling ²³	11.54	SERPINE1 PLG PLAT
15	ECM proteoglycans ⁶⁵	11.49	SERPINE1 ITGB3 ITGA2B
16	Formation of Fibrin Clot (Clotting Cascade) ⁶⁵ Show member pathways Blood Clotting Cascade ¹ Blood Coagulation Signaling Pathways ⁶⁴ Common Pathway of Fibrin Clot Formation ⁶⁵ Extrinsic Pathway of Fibrin Clot Formation ⁶⁵ Extrinsic Prothrombin Activation Pathway ⁶³ Intrinsic Pathway of Fibrin Clot Formation ⁶⁵	11.48	VWF SERPINE1 SERPINC1 PLG PLAT GP6
17	amb2 Integrin signaling ¹	11.42	SELP PLG PLAT GP1BA
18	Cell adhesion_Plasmin signaling ²³	11.41	PLG PLAT FGA
19	Platelet Aggregation Inhibitor Pathway, Pharmacodynamics ⁶⁰	11.34	VWF P2RY12 ITGB3 ITGA2B GP6 FGA
20	Platelet Adhesion to exposed collagen ⁶⁵	10.77	VWF GP6 GP1BA
21	Dissolution of Fibrin Clot ⁶⁵	10.75	SERPINE1 PLG PLAT
22	GP1b-IX-V activation signalling ⁶⁵	10.59	VWF GP1BA

Sources

GO Terms for Coronary Thrombosis

Cellular components related to Coronary Thrombosis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	plasma membrane	GO:0005886	10.22	SLC6A4 SERPINE1 SERPINC1 SELP POU2F3 PLG
2	extracellular region	GO:0005576	10.11	VWF SERPINF1 SERPINE1 SERPINC1 PLG PLAT
3	extracellular exosome	GO:0070062	10	VWF SERPINF1 SERPINE1 SERPINC1 PLG PLAT
4	extracellular space	GO:0005615	9.9	VWF SERPINF1 SERPINE1 SERPINC1 SELP PLG
5	blood microparticle	GO:0072562	9.73	SERPINC1 PLG ITGA2B FGA
6	platelet alpha granule lumen	GO:0031093	9.62	VWF SERPINE1 PLG FGA
7	cell surface	GO:0009986	9.61	PLG PLAT P2RY12 ITGB3 ITGA2B GP6
8	platelet alpha granule membrane	GO:0031092	9.54	SELP ITGB3 ITGA2B
9	platelet alpha granule	GO:0031091	9.48	VWF FGA
10	collagen-containing extracellular matrix	GO:0062023	9.23	VWF SERPINF1 SERPINE1 SERPINC1 PLG PLAT

Biological processes related to Coronary Thrombosis according to GeneCards Suite gene sharing:

(show all 20)

#	Name	GO ID	Score	Top Affiliating Genes
1	cell adhesion	GO:0007155	9.97	VWF SELP ITGB3 ITGA2B GP1BA
2	extracellular matrix organization	GO:0030198	9.8	VWF SERPINE1 ITGB3 ITGA2B FGA
3	platelet activation	GO:0030168	9.8	VWF P2RY12 ITGB3 GP6 GP1BA FGA
4	platelet aggregation	GO:0070527	9.77	P2RY12 ITGB3 ITGA2B GP1BA FGA
5	cell-matrix adhesion	GO:0007160	9.73	ITGB3 ITGA2B FGA
6	platelet degranulation	GO:0002576	9.7	VWF SERPINE1 SELP PLG ITGB3 ITGA2B
7	fibrinolysis	GO:0042730	9.65	SERPINE1 PLG PLAT GP1BA FGA
8	cellular response to ATP	GO:0071318	9.59	PTGS2 P2RY12
9	vasoconstriction	GO:0042310	9.58	SLC6A4 CRP
10	blood coagulation, intrinsic pathway	GO:0007597	9.57	VWF GP1BA
11	hemostasis	GO:0007599	9.56	VWF SERPINC1 PLG P2RY12 GP6 GP1BA
12	regulation of blood coagulation	GO:0030193	9.55	SERPINC1 GP1BA
13	negative regulation of macrophage derived foam cell differentiation	GO:0010745	9.54	ITGB3 CRP
14	positive regulation of leukocyte migration	GO:0002687	9.52	SELP ITGA2B
15	plasminogen activation	GO:0031639	9.51	PLAT FGA
16	negative regulation of fibrinolysis	GO:0051918	9.49	SERPINE1 PLG
17	negative regulation of lipid storage	GO:0010888	9.48	ITGB3 CRP
18	smooth muscle cell migration	GO:0014909	9.46	PLAT ITGB3
19	negative regulation of synaptic transmission, dopaminergic	GO:0032227	9.43	SLC6A4 PTGS2
20	blood coagulation	GO:0007596	9.32	VWF SERPINC1 PLG PLAT P2RY12 ITGB3

Molecular functions related to Coronary Thrombosis according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	serine-type endopeptidase inhibitor activity	GO:0004867	9.33	SERPINF1 SERPINE1 SERPINC1
2	protease binding	GO:0002020	9.02	VWF SERPINE1 SERPINC1 ITGB3 F3
3	fibrinogen binding	GO:0070051	8.96	ITGB3 ITGA2B

Sources

Sources for Coronary Thrombosis

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GARD

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MedlinePlus Genetics

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 05-Mar-2021)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia

Coronary Thrombosis

Aliases & Classifications for Coronary Thrombosis

MalaCards integrated aliases for Coronary Thrombosis:

Classifications:

External Ids:

Summaries for Coronary Thrombosis

Related Diseases for Coronary Thrombosis

Diseases related to Coronary Thrombosis via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Coronary Thrombosis:

Symptoms & Phenotypes for Coronary Thrombosis

MGI Mouse Phenotypes related to Coronary Thrombosis:

Drugs & Therapeutics for Coronary Thrombosis

Drugs for Coronary Thrombosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

Interventional clinical trials:

Inferred drug relations via UMLS 71 / NDF-RT 51 :

Cochrane evidence based reviews: coronary thrombosis

Genetic Tests for Coronary Thrombosis

Anatomical Context for Coronary Thrombosis

MalaCards organs/tissues related to Coronary Thrombosis:

Publications for Coronary Thrombosis

Articles related to Coronary Thrombosis:

Genes for Coronary Thrombosis

Genes related to Coronary Thrombosis (0 elite genes):

Variations for Coronary Thrombosis

Expression for Coronary Thrombosis

Pathways for Coronary Thrombosis

Pathways related to Coronary Thrombosis according to GeneCards Suite gene sharing:

GO Terms for Coronary Thrombosis

Cellular components related to Coronary Thrombosis according to GeneCards Suite gene sharing:

Biological processes related to Coronary Thrombosis according to GeneCards Suite gene sharing:

Molecular functions related to Coronary Thrombosis according to GeneCards Suite gene sharing:

Sources for Coronary Thrombosis

Inferred drug relations via UMLS ⁷¹ / NDF-RT ⁵¹ :